Advertisement

Topics

Pfizer promotes potential CEO successor Bourla

08:03 EST 15 Nov 2017 | pharmaphorum

Pfizer has promoted Albert Bourla, seen as a likely successor to incumbent CEO Ian Read, to the newly-created role of chief operating officer. The move could help Read focus on long-term strategy, allowing him to complete the mega-merger that he h...

Original Article: Pfizer promotes potential CEO successor Bourla

NEXT ARTICLE

More From BioPortfolio on "Pfizer promotes potential CEO successor Bourla"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...